학술논문
Long-Term Safety and Efficacy of Tocilizumab in Early Systemic Sclerosis–Interstitial Lung Disease :Open-Label Extension of a Phase 3 Randomized Controlled Trial
Document Type
Article
Author
Source
In: American Journal of Respiratory and Critical Care Medicine . (American Journal of Respiratory and Critical Care Medicine, 15 March 2022, 205(6):674-684)
Subject
Language
English
ISSN
15354970
1073449X
1073449X